Pfizer's Colossal $4.9 Billion Bet: A Game-Changer in the Obesity Treatment Arena
A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy